|
UTP23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44600000000039E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11449999999447E-05 |
| Normal-vs-Stage2 |
1.592760E-01 |
| Normal-vs-Stage3 |
1.028030E-01 |
| Normal-vs-Stage4 |
3.272600E-01 |
| Stage1-vs-Stage2 |
3.349600E-01 |
| Stage1-vs-Stage3 |
2.456400E-01 |
| Stage1-vs-Stage4 |
2.527600E-01 |
| Stage2-vs-Stage3 |
9.725000E-01 |
| Stage2-vs-Stage4 |
6.956200E-01 |
| Stage3-vs-Stage4 |
6.951200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.27409999999218E-05 |
| Normal-vs-AfricanAmerican |
2.974600E-04 |
| Normal-vs-Asian |
6.023900E-02 |
| Caucasian-vs-AfricanAmerican |
6.004800E-01 |
| Caucasian-vs-Asian |
9.345200E-01 |
| AfricanAmerican-vs-Asian |
7.770800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.71419999995504E-07 |
| Normal-vs-Female |
1.392430E-01 |
| Male-vs-Female |
1.630280E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.418580E-03 |
| Normal-vs-Extreme_Weight |
8.29440000000847E-05 |
| Normal-vs-Obese |
2.263600E-02 |
| Normal-vs-Extreme_Obese |
1.235650E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.351600E-01 |
| Normal_Weight-vs-Obese |
3.707400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.825000E-01 |
| Extreme_Weight-vs-Obese |
2.144200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.804400E-01 |
| Obese-vs-Extreme_Obese |
1.923190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.675600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.481100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.56149999988686E-07 |
| Normal-vs-Age(81-100Yrs) |
3.112400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.404240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.741300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.122100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.074250E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.976200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.897000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.86632999999992E-05 |
| Normal-VS-Type2 PRCC |
3.79870000000171E-06 |
| Normal-VS-KIRP CIMP |
6.033000E-01 |
| Normal-VS-Unclassified PRCC |
1.089810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.206600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.750090E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.512400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.802500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.005220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.713840E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43419999987238E-07 |
| Normal-vs-N1 |
8.628400E-01 |
| Normal-vs-N2 |
1.607050E-01 |
| N0-vs-N1 |
2.095500E-03 |
| N0-vs-N2 |
3.061000E-01 |
| N1-vs-N2 |
4.399000E-01 |
|
|
